[Experiences with cephradine (Sefril) in septical-surgery (author's transl)].
100 patients with septic-surgical diseases were treated with the cephalosporine-derivate Cephradine (Sefril). 79 patients were treated by surgical intervention in advance of the antibiotic therapy, 21 by Sefril in combination with conservative therapy only. The continuance of medication amounted to two weeks in 94%. A complete healing of the pyogenic infection was obtained in 86 patients. Complications occured in 6%.
D000038:Abscess / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D002481:Cellulitis / Q000188:drug therapy; D002511:Cephalosporins / Q000627:therapeutic use*; D002515:Cephradine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007239:Infections / Q000188:drug therapy* / Q000601:surgery; D008297:Male; D008875:Middle Aged; D010019:Osteomyelitis / Q000188:drug therapy; D010304:Paronychia / Q000188:drug therapy; D010538:Peritonitis / Q000188:drug therapy; D014946:Wound Infection / Q000188:drug therapy
D002511:Cephalosporins; D002515:Cephradine
Erfahrungen mit Cefradin (Sefril) in der septischen Chirurgie